Skip to main content
Premium Trial:

Request an Annual Quote

Blueprint Initiative Announces Funding for Asian Branch, Launch of European Branch

NEW YORK, Aug 2 (GenomeWeb News) - The Blueprint Initiative said today that it has secured core funding to support the launch of Blueprint Asia in Singapore.


The Singapore effort, said Blueprint, will be supported by the Economic Development Board in partnership with the Genomics Institute of Singapore, the National University of Singapore, and industry partner Sun Microsystems. The exact amount of funding Blueprint Asia will receive was not disclosed.


"In June of 2004, we surpassed adding 80,000 interactions into the BIND database with curation activities underway at the Blueprint Initiative's headquarters in Canada," Christopher Hogue, a Blueprint principal investigator, said in a statement. "With the support for the Blueprint Initiative's Asian nodes, we will employ up to another 40 curators who will over five years enter an additional 60,000 biomolecular interactions."


Blueprint also announced today the launch of Blueprint Europe and its plan to partner with Nature Publishing Group to curate all biomolecular interactions across all titles in every manuscript published throughout the company's history.


Blueprint said that its European branch will provisionally be located in London while funding is pursued.


The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.